Multitarget inhibition of CDK2, EGFR, and tubulin by phenylindole derivatives: Insights from 3D-QSAR, molecular docking, and dynamics for cancer therapy
Table 7
Docking score of the identified compounds against Cyclin-Dependent Kinase 2 (PDB ID: 2A4L), Tubulin (PDB ID: 1AS0), and Epidermal Growth Factor Receptor tyrosine kinase (PDB ID: 1M17) for anti-cancer activity.